Bracciamà Emanuele, Sapuppo Annamaria, Rapisarda Laura, Siciliano Enrico, Caciotti Anna, Morrone Amelia, Ruggieri Martino, Cantarella Giuseppina, Bernardini Renato, Bertino Gaetano
Hepatology Unit, Department of Clinical and Experimental Medicine, Policlinico "G. Rodolico-San Marco" Hospital, University of Catania, 95123 Catania, Italy.
Pediatric Clinic, Department of Clinical and Experimental Medicine, Policlinico "G. Rodolico-San Marco" Hospital, University of Catania, 95123 Catania, Italy.
Curr Issues Mol Biol. 2024 Jun 17;46(6):6112-6120. doi: 10.3390/cimb46060365.
Wilson's disease (WD) is a biallelic disease-causing variant in the gene on chromosome 13q14.3 that results in copper accumulation in many organs, particularly the liver and brain. The phenotypic spectrum is wide and symptoms at onset can be heterogeneous. We describe two Sicilian siblings, a young man and his elder sister, both compound heterozygous for the variants c.1286-2A>G and c.2668G>A (p.Val890Met) in the gene. The male patient presented with liver cirrhosis, which quickly progressed to end-stage liver disease (Child-Pugh score = C10), while his sister had moderate steatotic liver disease (SLD). Our findings highlight that SLD may not always be related to obesity in overweight patients, especially when there are other potential risk factors such as a family history of chronic liver disease, or the persistence of high transaminase despite the adoption of adequate dietary and pharmacological intervention. Screening for conditions such as WD could identify patients at risk of developing SLD and avoid delays in diagnosis. Phenotypic variability in WD is considerable; therefore, further studies are needed to identify which WD patients have a greater risk of developing SLD and determine factors that can predict the severity of the disease.
威尔逊病(WD)是一种由位于13号染色体q14.3区域的基因双等位致病变异引起的疾病,该变异导致铜在许多器官中蓄积,尤其是肝脏和大脑。其表型谱广泛,起病时症状可能多种多样。我们描述了两名西西里岛的兄弟姐妹,一名年轻男子及其姐姐,他们在该基因中均为c.1286 - 2A>G和c.2668G>A(p.Val890Met)变异的复合杂合子。男性患者表现为肝硬化,并迅速进展为终末期肝病(Child - Pugh评分 = C10),而他的姐姐患有中度脂肪性肝病(SLD)。我们的研究结果强调,SLD在超重患者中可能并不总是与肥胖相关,特别是当存在其他潜在风险因素时,如慢性肝病家族史,或尽管采取了适当的饮食和药物干预但转氨酶仍持续升高。对WD等疾病进行筛查可以识别出有发展为SLD风险的患者,并避免诊断延误。WD的表型变异性很大;因此,需要进一步研究以确定哪些WD患者发展为SLD的风险更高,并确定可预测疾病严重程度的因素。